Shire PLC (SHP) Receives “Overweight” Rating from JPMorgan Chase & Co.
Shire PLC (LON:SHP)‘s stock had its “overweight” rating reaffirmed by stock analysts at JPMorgan Chase & Co. in a research note issued on Monday.
Several other brokerages also recently commented on SHP. Deutsche Bank AG reaffirmed a “buy” rating and set a GBX 6,000 ($74.26) price objective on shares of Shire PLC in a research report on Wednesday, July 13th. Liberum Capital reaffirmed a “buy” rating and set a GBX 5,500 ($68.07) price objective on shares of Shire PLC in a research report on Friday, July 29th. Goldman Sachs Group Inc. reaffirmed a “conviction-buy” rating and set a GBX 6,300 ($77.97) price objective on shares of Shire PLC in a research report on Thursday, September 29th. BNP Paribas reaffirmed an “outperform” rating and set a GBX 5,700 ($70.54) price objective on shares of Shire PLC in a research report on Monday, August 1st. Finally, Berenberg Bank reaffirmed a “buy” rating and set a GBX 5,800 ($71.78) price objective on shares of Shire PLC in a research report on Wednesday, July 6th. One analyst has rated the stock with a sell rating, one has issued a hold rating and seventeen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of GBX 5,841.33 ($72.29).
Shire PLC (LON:SHP) opened at 5118.00 on Monday. The firm’s market capitalization is GBX 34.95 billion. Shire PLC has a one year low of GBX 2,707.19 and a one year high of GBX 5,377.00. The company’s 50-day moving average is GBX 5,005.03 and its 200-day moving average is GBX 4,600.81.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/17/shire-plc-shp-receives-overweight-rating-from-jpmorgan-chase-co-2.html
The company also recently disclosed a dividend, which was paid on Friday, October 7th. Investors of record on Thursday, September 8th were issued a GBX 3.51 ($0.04) dividend. This represents a yield of 0.07%. The ex-dividend date of this dividend was Thursday, September 8th.
In other news, insider Dominic Blakemore acquired 133 shares of the firm’s stock in a transaction that occurred on Friday, September 30th. The stock was bought at an average price of GBX 5,010 ($62.00) per share, with a total value of £6,663.30 ($8,246.66).
Shire PLC Company Profile
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.